KR102141609B1 - Manufacturing method for onion juice - Google Patents
Manufacturing method for onion juice Download PDFInfo
- Publication number
- KR102141609B1 KR102141609B1 KR1020200050238A KR20200050238A KR102141609B1 KR 102141609 B1 KR102141609 B1 KR 102141609B1 KR 1020200050238 A KR1020200050238 A KR 1020200050238A KR 20200050238 A KR20200050238 A KR 20200050238A KR 102141609 B1 KR102141609 B1 KR 102141609B1
- Authority
- KR
- South Korea
- Prior art keywords
- onion
- active ingredient
- ethanol
- solvent
- concentration
- Prior art date
Links
- 241000234282 Allium Species 0.000 title claims abstract description 99
- 235000002732 Allium cepa var. cepa Nutrition 0.000 title claims abstract description 99
- 235000011389 fruit/vegetable juice Nutrition 0.000 title claims abstract description 43
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 239000004480 active ingredient Substances 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 31
- 239000002904 solvent Substances 0.000 claims abstract description 21
- 239000007788 liquid Substances 0.000 claims abstract description 20
- 230000005070 ripening Effects 0.000 claims abstract description 15
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 238000005406 washing Methods 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 54
- 239000000284 extract Substances 0.000 claims description 27
- 230000032683 aging Effects 0.000 claims description 25
- 239000000243 solution Substances 0.000 claims description 22
- 239000011259 mixed solution Substances 0.000 claims description 10
- 230000001093 anti-cancer Effects 0.000 abstract description 13
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 49
- 210000004027 cell Anatomy 0.000 description 34
- 235000005875 quercetin Nutrition 0.000 description 25
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 24
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 24
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 24
- 229960001285 quercetin Drugs 0.000 description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000004128 high performance liquid chromatography Methods 0.000 description 12
- 230000008569 process Effects 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 206010009944 Colon cancer Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000011550 stock solution Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 201000007270 liver cancer Diseases 0.000 description 5
- 208000014018 liver neoplasm Diseases 0.000 description 5
- 201000005202 lung cancer Diseases 0.000 description 5
- 208000020816 lung neoplasm Diseases 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 208000029742 colonic neoplasm Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000003405 preventing effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- -1 calcium phosphate Natural products 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 238000003026 viability measurement method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- VNFYMAPAENTMMO-UHFFFAOYSA-N 5-chloro-2-methylquinoline Chemical compound ClC1=CC=CC2=NC(C)=CC=C21 VNFYMAPAENTMMO-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000012901 Milli-Q water Substances 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940008075 allyl sulfide Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- ALVPFGSHPUPROW-UHFFFAOYSA-N dipropyl disulfide Chemical compound CCCSSCCC ALVPFGSHPUPROW-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000021581 juice product Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/04—Extraction of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
본 발명은 양파즙 제조 방법에 관한 것으로, 보다 상세하게는 케르세틴 함유량을 높인 양파즙 제조 방법에 관한 것이다.The present invention relates to a method for producing onion juice, and more particularly, to a method for producing onion juice with a higher quercetin content.
양파는 예로부터 건강에 유효한 야채로 여러 음식에 사용되어 오고 있다. 양파는 주로 비늘줄기를 식용으로 하는데, 비늘줄기에서 나는 독특한 냄새는 이황화프로필황화알릴 등의 화합물 때문이다. 이것은 생리적으로 소화액 분비를 촉진하고 흥분발한이뇨 등의 효과가 있다. 또한 비늘줄기에는 각종 비타민과 함께 칼슘인산 등의 무기질이 들어 있어 혈액 중의 유해 물질을 제거하는 작용이 있다. 비늘줄기는 샐러드나 수프, 그리고 고기 요리에 많이 사용되며 각종 요리에 향신료 등으로 이용된다. 잎은 100g 중에 비타민A 5,000IU, 비타민C 45mg, 칼슘 80mg, 마그네슘 24mg, 칼륨 220mg이 들어 있다.Onions have been used in various foods since ancient times as a healthy vegetable. Onions are mainly used for edible stems, and the peculiar smell from scale stems is due to compounds such as propyl disulfide and allyl sulfide. This physiologically promotes the secretion of digestive fluids and has the effect of excitement and diuresis. In addition, the scale stem contains various vitamins and minerals such as calcium phosphate, which has the effect of removing harmful substances from the blood. Scale stems are often used in salads, soups, and meat dishes, and as spices in various dishes. The leaves contain 5,000 IU of vitamin A, 45 mg of vitamin C, 80 mg of calcium, 24 mg of magnesium, and 220 mg of potassium in 100 g.
특히, 양파의 효능으로는 피를 맑게 한다는 점인데. 이는 양파의 유효 성분 중 하나인 케르세틴에 의한 효능이다.In particular, the effect of onion is that it clears the blood. This is the efficacy of quercetin, one of the active ingredients in onions.
케르세틴은 플라보노이드의 일종으로 식물에 널리 분포된 색소로 인체내에서 암예방, 항염증, 당뇨병 개선과 합병증 예방, 니코틴 해독, 피부암 예방, 항 바이러스 작용을 하는 것으로 알려져 있고, 특히나 혈관장애를 방지하는데 탁월한 역할을 수행한다.Quercetin is a kind of flavonoid and widely distributed in plants. It is known to have cancer prevention, anti-inflammatory, diabetes improvement and complications prevention, nicotine detoxification, skin cancer prevention, and anti-viral action in the human body. Play a role.
양파에 많은 케르세틴은 특히 흡수, 대사가 좋아 혈장의 농도를 안정되게 유지시키므로, 혈관계의 병의 예방, 진전 저지에 효과 있게 작용하는 것이다.Quercetin, which is abundant in onion, has good absorption and metabolism, and thus maintains a stable plasma concentration, so it is effective in preventing diseases of the vascular system and preventing progress.
또한 당뇨병 환자에게는 혈당 조절과 항산화물질의 보급 등이 당뇨병에 의한 합병증의 예방, 진정방지에 필수적인데, 상술한 바와 같이 양파에는 혈당을 내려주는 함유화합물과 항산화물질인 케르세틴이 많이 함유되어 있어 당뇨병 환자에게 큰 도움이 되고 있다.In addition, the control of blood sugar and the supply of antioxidants to diabetic patients are essential for the prevention and sedation of complications caused by diabetes. As mentioned above, onions contain a lot of compounds that lower blood sugar and quercetin, an antioxidant, so people with diabetes Has been a great help.
따라서 이러한 양파의 장점을 살려서 양파를 손쉽게 섭취할 수 있도록 음료 형태의 양파즙이 다양한 제품으로 나와 있다.Therefore, taking advantage of these onions, onion juice in the form of a drink is presented in various products so that onions can be easily consumed.
예를 들어 대한민국 공개특허 제10-2012-0077732호에는 돈피분말을 함유한 양파즙의 제조방법 및 상기 방법으로 제조된 양파즙이 개시되어 있다.For example, Republic of Korea Patent Publication No. 10-2012-0077732 discloses a method of manufacturing onion juice containing a pig skin and onion juice prepared by the above method.
그런데 다양한 방식으로 양파즙을 생성 또는 제조함에 있어서, 상술한 바와 같이 탁월한 효과를 나타내는 케르세틴을 최대한 많이 포함시키는 것이 관건이므로, 결국 양파즙 제조에 있어서는 케르세틴 추출 효율성을 극대화하는 것이 필요한 것이다.However, in producing or manufacturing onion juice in various ways, it is a key to include as much quercetin as possible, which has an excellent effect, as described above, and thus it is necessary to maximize the efficiency of quercetin extraction in onion juice production.
본 발명은 상기한 종래의 요청에 부응하기 위해 안출된 것으로서, 그 목적은 동일한 양의 양파로부터 최대한 많은 양의 케르세틴이 포함된 양파즙을 제조하기 위한 방법을 제공하는 것이다. The present invention has been devised to meet the above-mentioned conventional requests, and its object is to provide a method for preparing onion juice containing as much quercetin as possible from the same amount of onions.
상기한 목적을 달성하기 위해 본 발명에 따른 양파즙 제조 방법은, 양파를 세척한 후, 껍질을 분리하는 단계와; 상기 단계에서 분리된 양파 껍질을 용매를 이용하여 숙성시켜 숙성액을 생성하는 단계와; 껍질이 제거된 생양파를 작은 크기로 부수는 단계와; 상기 단계의 숙성액과 상기 단계에서 가공된 생양파를 혼합하여 혼합액을 생성하는 단계와; 상기 단계의 혼합액에 용매를 투입하여 유효성분 추출액을 생성하는 단계와; 상기 단계의 유효성분 추출액에서 용매를 제거하는 단계를 포함할 수 있다.In order to achieve the above object, a method for preparing onion juice according to the present invention includes washing the onion and separating the peel; A step of aging the onion peel separated in the step using a solvent to produce a aging liquid; Crushing the peeled raw onion into small sizes; Mixing the aged liquid of the step and the raw onion processed in the step to produce a mixed liquid; Generating an active ingredient extract by adding a solvent to the mixed solution of the step; It may include the step of removing the solvent from the active ingredient extract of the step.
여기서, 상기 단계의 용매는 에탄올일 수 있다.Here, the solvent of the step may be ethanol.
여기서, 분리된 양파 껍질을 65% ~ 75% 에탄올을 이용하여 숙성시켜 숙성액을 생성할 수 있다.Here, the separated onion peel may be aged using 65% to 75% ethanol to produce a aging liquid.
여기서 에탄올을 제거하는 할 수 있다.Here, ethanol can be removed.
여기서 혼합액에 45% ~ 55% 에탄올을 투입하여 유효성분 추출액을 생성할 수 있다.Here, 45% to 55% ethanol may be added to the mixed solution to generate an active ingredient extract.
여기서, 숙성 기간은 18개월 ~ 24개월이고, 7℃ ~ 12℃ 이하에서 저온 숙성할 수 있다.Here, the aging period is 18 months to 24 months, and may be aged at a low temperature of 7°C to 12°C or less.
여기서, 숙성액을 80℃ ~ 85℃의 온도에서 에탄올을 제거하고, 유효성분 추출액을 80℃ ~ 85℃의 온도에서 에탄올을 제거할 수 있다.Here, the aging solution can remove ethanol at a temperature of 80°C to 85°C, and the active ingredient extract can remove ethanol at a temperature of 80°C to 85°C.
여기서, 상기 단계의 숙성액을 70℃ ~ 75℃의 온도, 압력 40cmHg에서 감압 농축하여 농도가 10 ∼ 15 Brix가 되도록 할 수 있다.Here, the aging liquid of the above step may be concentrated under reduced pressure at a temperature of 70°C to 75°C and a pressure of 40 cmHg to have a concentration of 10 to 15 Brix.
여기서 상기 유효성분 추출액을 70℃ ~ 75℃의 온도, 압력 40cmHg에서 감압농축하여 농도가 20 ∼ 25 Brix가 되도록 할 수 있다.Here, the active ingredient extract may be concentrated under reduced pressure at a temperature of 70°C to 75°C and a pressure of 40 cmHg to have a concentration of 20 to 25 Brix.
이상 설명한 바와 같이 본 발명에 따르면, 케르세틴 등을 포함하는 유효물질을 추출양을 극대화함으로써, 양파즙의 항암효과를 높일 수 있다.As described above, according to the present invention, the anti-cancer effect of onion juice can be enhanced by maximizing the extraction amount of an active substance containing quercetin or the like.
도 1은 본 발명의 일 실시예에 따른 양파즙 제조 방법의 전체적인 과정이고,
도 2 내지 도 5는 도 1에 따른 과정을 통해 생성된 양파즙과 타사 양파즙 간의 항암 효과를 나타낸 도면이다.1 is an overall process of a method for preparing onion juice according to an embodiment of the present invention,
2 to 5 is a view showing the anti-cancer effect between the onion juice and the other onion juice produced through the process according to FIG.
이하에서는 첨부도면을 참조하여 본 발명에 대해 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.
이하 본 발명에 따른 각 실시예는 본 발명의 이해를 돕기 위한 하나의 예에 불과하고, 본 발명이 이러한 실시예에 한정되는 것은 아니다. 특히 본 발명은 각 실시예에 포함되는 개별 단계 중 적어도 어느 하나 이상의 조합으로 구성될 수 있다.Hereinafter, each embodiment according to the present invention is only one example to help understanding of the present invention, and the present invention is not limited to these embodiments. In particular, the present invention may be composed of a combination of at least one or more of the individual steps included in each embodiment.
특히, 편의상 청구 범위의 일부 청구항에는 '(a)'와 같은 알파벳을 포함시켰으나, 이러한 알파벳이 각 단계의 순서를 규정하는 것은 아니다.In particular, for convenience, some claims in the claims include alphabets such as'(a)', but these alphabets do not define the order of each step.
본 발명의 일 실시예에 따른 양파즙 제조를 위한 전체적인 공정은 도 1에 도시된 바와 같다.The overall process for preparing onion juice according to an embodiment of the present invention is as shown in FIG. 1.
동 도면에 도시된 바와 같이 본 발명의 일 실시예에 따른 양파즙 제조 방법은 크게 양파 껍질을 분리하는 단계, 분리된 양파 껍질을 숙성시키는 단계, 껍질이 제거된 생양파를 작은 크기로 부수거나 으깨는 단계, 양파 껍질을 이용한 숙성액과 작은 크기로 부수어지거나 으깨어진 생양파를 혼합하여 혼합액을 생성하는 단계, 혼합액에서 유효성분을 추출하는 단계, 유효성분 추출액에서 용매를 제거하는 단계를 포함하여 이루어질 수 있다.As shown in the drawing, the method for preparing onion juice according to an embodiment of the present invention largely separates the onion peel, the step of aging the separated onion peel, and breaks or crushes the peeled fresh onion into small sizes. The step, mixing the aging liquid using onion peels and crushed or crushed green onions in a small size to produce a mixed solution, extracting the active ingredient from the mixed solution, and removing the solvent from the active ingredient extract Can.
각 단계별로 설명하면 다음과 같다.The explanation for each step is as follows.
양파를 세척한 후 껍질을 분리하고, 그 분리된 양파 껍질을 숙성시키게 되는데, 여기서 양파 껍질에는 소정의 용매를 섞은 후에 숙성을 하게 된다.After washing the onion, the skin is separated, and the separated onion skin is aged, where the onion skin is aged after mixing a predetermined solvent.
예를 들어 열수추출과 비교할 때 그 효과가 뛰어난 에탄올 추출법을 이용하여 유효성분이 추출되도록 하면서 숙성할 수 있는데, 일 예로 껍질을 68% ~ 75% 에탄올을 이용하여 숙성시켜 숙성액을 생성할 수 있다.For example, it can be aged while allowing the active ingredient to be extracted using an ethanol extraction method, which is superior in effect to hot water extraction. For example, the peel can be aged using 68% to 75% ethanol to produce a aging liquid.
이처럼 본 발명의 가장 큰 특징은 양파 껍질을 별도로 분리하여 숙성시키는 과정을 거친다는 점이다.As such, the biggest feature of the present invention is that it undergoes a process of separately separating onion skins and ripening.
이러한 양파 껍질에 대한 숙성 기간은 18개월 ~ 24개월이고, 5℃ ~ 10℃ 이하에서 저온 숙성함이 바람직하다.The aging period for the onion peel is 18 months to 24 months, and it is preferable to perform low temperature aging at 5°C to 10°C or less.
이러한 숙성 기간을 통해 양파 껍질에 포함되어 있던 케르세틴을 포함하는 많은 유효 물질(유효 성분)들이 빠져 나오게 된다.Through this aging period, many active substances (active ingredients) including quercetin contained in the onion peel are released.
숙성 기간이 지난 후에는 숙성을 위한 용매, 예를 들어 에탄올을 제거하는 단계를 거칠 수 있다.After the aging period, a step for removing a solvent for aging, for example, ethanol, may be performed.
예를 들어 숙성액을 80℃ ~ 85℃의 온도인 중불에서 가열하여 에탄올을 제거할 수 있다.For example, the aging liquid can be removed by heating the medium at a temperature of 80° C. to 85° C. over medium heat.
1기압 하에서 에탄올의 끓는점은 대략 78℃ 정도가 되므로, 이러한 온도만으로도 에탄올의 대부분을 제거할 수 있다.Since the boiling point of ethanol is about 78°C under 1 atmosphere, most of the ethanol can be removed even at this temperature.
다른 예로써 양파 껍질 숙성액을 압력 40cmHg에서 70℃ ~ 75℃의 온도로 감압 농축할 수 있는데, 이때 숙성액의 농도가 10 ∼ 15 Brix가 되도록 함이 바람직하다.As another example, the onion peel ripening solution may be concentrated under reduced pressure at a temperature of 40° C. to 75° C. under a pressure of 40 cm Hg, wherein the concentration of the ripening solution is preferably 10 to 15 Brix.
한편, 껍질이 제거된 양파는 별도로 분쇄하거나 으깨는데, 과일 또는 야채의 분쇄 방법 그 자체는 공지된 기술에 해당하므로 보다 상세한 설명은 생략한다.On the other hand, the peeled onions are separately crushed or crushed, and the pulverizing method of the fruit or vegetable itself corresponds to a known technique, so a detailed description thereof will be omitted.
분쇄되거나 으깨어진 생양파를 앞서 양파 껍질 숙성액(바람직하게는 에탄올이 제거된 숙성액)과 혼합하여 혼합액을 생성한다.The pulverized or crushed raw onion is mixed with the onion peel ripening solution (preferably, the ethanol-removed ripening solution) to form a mixed solution.
즉, 혼합액에는 양파 껍질을 숙성하여 생성된 숙성액(물론 이러한 숙성액에는 케르세틴을 포함하는 다양한 유효성분들이 포함되어 있음)과 생양파가 포함되게 되는 것이다.That is, the mixed solution will contain the ripening solution produced by ripening the onion peel (of course, the ripening solution contains various active ingredients including quercetin) and fresh onion.
이러한 혼합액에 유효 성분의 2차 추출을 위해 용매를 투입하여 유효성분 추출액을 생성한다.An active ingredient extract is generated by adding a solvent to the mixture for secondary extraction of the active ingredient.
예를 들어 열수추출과 비교할 때 그 효과가 뛰어난 에탄올 추출법을 이용하여 유효성분을 추출할 수 있는데, 일 예로 혼합액에 45% ~ 55% 에탄올을 투입하여 유효성분 추출액을 생성할 수 있다.For example, an active ingredient can be extracted using an ethanol extraction method that is superior in effect to hot water extraction. For example, an active ingredient extract may be generated by adding 45% to 55% ethanol to a mixed solution.
이렇게 유효성분 추출액이 생성된 후에, 기 투입되었던 용매, 예를 들어 에탄올을 제거하는 과정을 거치게 되는데, 예를 들어 유효성분 추출액을 80℃ ~ 85℃의 온도로 가열하여 에탄올을 제거할 수 있다.After the active ingredient extract is generated, a process of removing the previously added solvent, for example, ethanol, is performed. For example, the active ingredient extract may be heated to a temperature of 80°C to 85°C to remove ethanol.
다른 예로써, 유효성분 추출액을 압력 40cmHg에서 70℃ ~ 75℃의 온도로 감압농축할 수 있고, 이때 농도가 20 ∼ 25 Brix가 되도록 함이 바람직하다.As another example, the active ingredient extract may be concentrated under reduced pressure at a pressure of 40 cmHg to a temperature of 70° C. to 75° C. At this time, the concentration is preferably 20 to 25 Brix.
이하에서는 본 발명 따른 양파즙 제조 방법의 구체적인 실시예들과, 이러한 제조 방법에 따른 양파즙 및 이에 대한 희석액과 대조군(다른 방식으로 제조된 양파즙) 및 이의 희석액 간의 비교를 하도록 한다.Hereinafter, specific examples of the method for preparing onion juice according to the present invention and onion juice according to the method and a diluent and control (onion juice prepared in different ways) and dilutions thereof will be compared.
(실시예 1)(Example 1)
70% 에탄올 500g에 양파 껍질 100g을 넣고, 10℃에서 18개월 동안 저온 숙성하여 숙성액을 생성한 후에 73℃의 온도, 압력 40cmHg에서 감압농축하여 농도가 13 Brix가 되도록 하고, 껍질을 깐 생양파 1kg(5개에서 6개 분량임)을 으깬 후에 숙성액과 혼합하고, 이러한 혼합액에 상온에서 50% 에탄올 1kg을 투여하여 5시간 기다려 유효 성분 추출액이 되도록 하고, 이러한 유효 성분 추출액을 압력 40cmHg 하의 73℃의 온도에서 감압농축하여 농도가 23 Brix가 되도록 하였다.After adding 100 g of onion peel to 500 g of 70% ethanol, low temperature aging at 10° C. for 18 months to produce a aging liquid, and then concentrating under reduced pressure at a temperature of 73° C. and a pressure of 40 cm Hg to achieve a concentration of 13 Brix, peeled raw onion After crushing 1 kg (5 to 6 portions), mix with the aging solution, and 1 kg of 50% ethanol at room temperature to the mixed solution, wait 5 hours to become an active ingredient extract, and the active ingredient extract is 73 under a pressure of 40 cmHg. Concentration under reduced pressure at a temperature of ℃ to a concentration of 23 Brix.
이러한 실시예와 타사에서 생산 판매되는 동일한 농도를 가지는 양파즙 및 비교군 간의 항암효능을 측정하였고, 그 과정 및 결과는 다음과 같다.The anticancer efficacy between these examples and onion juice having the same concentration as produced and sold by a third party and a comparison group was measured, and the process and results are as follows.
1. 암세포증식억제효과측정1. Cancer cell proliferation inhibitory effect measurement
1) 시험방법: MTT assay method 배제분석법1) Test method: MTT assay method Exclusion analysis method
2) Cell lines : 대장암세포, 폐암세포 및 간암세포등의 암세포주를이용.2) Cell lines: Cancer cell lines such as colon cancer cells, lung cancer cells, and liver cancer cells are used.
3) 시험시료: 본 발명에 따른 양파액즙, 타사2곳의 시판 양파액즙 분석, 비교.3) Test sample: Onion juice according to the present invention, commercial onion juice analysis of two other companies, comparison.
4) 용량단계: 본 발명에 따른 양파즙액을 조정하여 2배농축액, 원액, 5배 희석액, 10배 희석액 등으로 농도 단계별로 처리.4) Dose step: Adjust the onion juice solution according to the present invention to treat the concentration step by step with a 2x concentrated solution, a stock solution, a 5x diluted solution, or a 10x diluted solution.
2. 시험과정2. Test process
1) 세포주배양1) Cell line culture
(1) 세포주배양: (1) Cell line culture:
각 암세포주를 10% fetal bovine serum 이 포함된 RPMI-1640 또는DMEM 배지에 배양Culture each cancer cell line in RPMI-1640 or DMEM medium containing 10% fetal bovine serum
(2) 세포주관리: 2-3일마다 trypsin-EDTA 용액을 사용하여 계대배양을(2) Cell line management: passage culture using trypsin-EDTA solution every 2-3 days
실시하여 관리.Management by conduct.
2) 세포생존율측정2) Cell viability measurement
(1) 세포분주: 배양된 세포에 RPMI-1640 또는 DMEM 배지를 첨가하여(1) Cell division: RPMI-1640 or DMEM medium was added to the cultured cells.
cell을 2ㅧ105cells/ml 되게 24 well plate에1ml씩 분주.Dispense 1 ml of cells into 24 well plates at 2 ㅧ 105 cells/ml.
(2) 세포분주후 1시간정도 안정화시킨후 시료를 농도별로 10ul씩첨가.(2) After cell dispensing, stabilize for about 1 hour, and then add 10ul of each sample for each concentration.
첨가한다.Add.
(3) 24시간or 48시간 배양후 MTT (5mg/ml in PBS) 10ul를 각 well에(3) After culture for 24 hours or 48 hours, 10ul of MTT (5mg/ml in PBS) was added to each well.
첨가adding
(4) 4시간 인큐베이션후 생성된 formazan결정을 DMSO로 용해시켜 ELISA plate reader로 595nm에서 흡광도를 측정하여 평가.(4) After incubation for 4 hours, formazan crystals generated were dissolved with DMSO and measured by measuring absorbance at 595 nm with an ELISA plate reader.
3) 세포생존 및 세포사 측정3) Cell survival and cell death measurement
(1) 4-5일 배양된 세포를 2ㅧ105cells/dish의 밀도로 동량으로 한 culture dishes에 접종하여 안정화를 위해 하루 동안 배양(1) Cells cultured for 4-5 days were inoculated into culture dishes in the same amount at a density of 2ㅧ105 cells/dish, and cultured for one day for stabilization.
(2) 단계별로 희석된 양파액즙을 처리한 후 부가적으로 2일간 배양.(2) After the onion juice was diluted step by step, cultured for an additional 2 days.
(3) PBS로 세척하고 trypsin-EDTA를 이용하여 수확.(3) Wash with PBS and harvest using trypsin-EDTA.
상술한 과정을 통해 테스트한 결과, 도 2 내지 도 5와 같은 결과가 나타났다.As a result of testing through the above-described process, results as shown in FIGS. 2 to 5 were obtained.
도 2는 대장암세포A 생존력(% of 대조군)을 나타낸 것인데, 대장암세포A가 타사 제품의 양파즙보다 본 발명에 따른 양파즙의 농축액, 원액, 희석액에서 생존율이 현저히 떨어졌음을 알 수 있다.2 shows the viability of colon cancer cell A (% of control), and it can be seen that colon cancer cell A had a significantly lower survival rate in concentrate, stock solution, and dilution of onion juice according to the present invention than onion juice of other companies.
도 3은 대장암세포B 생존력(% of 대조군)을 나타낸 것인데, 대장암세포B가 타사 제품의 양파즙보다 본 발명에 따른 양파즙의 농축액, 원액, 희석액에서 생존율이 현저히 떨어졌음을 알 수 있고, 2배 농축액에서는 대장암세포B의 생존율이 타사가 더 떨어졌음을 알 수 있다.Figure 3 shows the colorectal cancer cell B viability (% of control), it can be seen that the colorectal cancer cell B survival rate is significantly lower in the concentrate, stock solution, dilution of onion juice according to the present invention than the other company's onion juice, 2 times In the concentrate, it can be seen that the survival rate of colorectal cancer cells B is lower.
도 4는 폐암세포A 생존력(% of 대조군)을 나타낸 것인데, 폐암 세포A가 타사 제품의 양파즙보다 본 발명에 따른 양파즙의 농축액, 원액, 희석액에서 생존율이 현저히 떨어졌음을 알 수 있다.Figure 4 shows the lung cancer cell A viability (% of control), it can be seen that the lung cancer cell A survival rate is significantly lower in the concentrate, stock solution, dilution of onion juice according to the present invention than onion juice of other companies.
또한 도 5는 간암세포 생존력(% of 대조군)을 나타낸 것인데, 간암세포가 타사 제품의 양파즙보다 본 발명에 따른 양파즙의 농축액, 원액, 희석액에서 생존율이 현저히 떨어졌음을 알 수 있다.In addition, Figure 5 shows the liver cancer cell viability (% of control), it can be seen that the liver cancer cell survival rate is significantly lower in the concentrate, stock solution, dilution of onion juice according to the present invention than the onion juice of other products.
테스트 결과: 이처럼 본 발명에 따른 양파즙과 타사의 양파즙 제품과 비교할 때, 2종의 대장암세포주 A와 B, 간암세포주, 폐암세포주에 적용하여 함암 효능을 테스트하였고, 각 양파즙의 원액에 10배희석, 5배 희석, 원액, 2배 농축액으로 농도 별로 조장하여 각 세포주에 처리하고 24시간 인큐베이션한 후 MTT 용액을 처리하여 세포생존률 측정법을 통해 실시한 결과, 본 발명에 따른 양파즙의 항암성은 대장안세포주 A와 B, 간암세포주, 폐암세포주에 대하여 모두 명확하게 나타났으며, 원액의 농도에서 시험방법과 같은 조건으로 적용한 경우 가장 뚜렷한 항암성을 보였다.Test results: Compared to onion juice and other onion juice products according to the present invention, the cancer efficacy was tested by applying to two types of colorectal cancer cell lines A and B, liver cancer cell line, and lung cancer cell line. 10 times dilution, 5 times diluted, undiluted solution, 2 times concentrated, concentrated to each concentration, treated to each cell line, incubated for 24 hours, and then treated with MTT solution to perform cell viability measurement, and the anticancer properties of onion juice according to the present invention The colon cell lines A and B, the liver cancer cell line, and the lung cancer cell line were all clearly shown, and the most pronounced anti-cancer properties when applied under the same conditions as the test method at the concentration of the stock solution.
타사 2곳의 제품과 비교시 타사 제품의 원액을 2배 농축하여 적용한 경우에 본 발명에 따른 양파즙 원액의 항암효능력과 다소 비슷해지나, 본 발명에 따른 양파즙의 생산물보다는 낮은 항암 능력을 보였다.When compared to the products of other companies' two places, the concentrate of the other company's products was applied twice as concentrated, and it was somewhat similar to the anticancer efficacy of the onion juice stock solution according to the present invention, but showed lower anticancer capacity than the product of the onion juice according to the present invention. .
이하에서는 상술한 실시예 1과 비교되는 또 다른 실시예들에 대해 비교하도록 한다.Hereinafter, other embodiments compared with the above-described embodiment 1 will be compared.
(비교예 1)(Comparative Example 1)
실시예 1과 동일하게 실시하되, 양파껍질에 대한 저온 숙성 기간을 24시간이 되도록 하였다.The same procedure as in Example 1 was carried out, so that the low-temperature aging period for the onion peel was set to 24 hours.
(비교예 2)(Comparative Example 2)
실시예 1과 동일하게 실시하되, 양파껍질의 숙성액을 제조할 때 50% 에탄올 500g을 이용하였다.It was carried out in the same manner as in Example 1, when preparing the ripening solution of the onion peel was used 500g of 50% ethanol.
(비교예 3)(Comparative Example 3)
실시예 1과 동일하게 실시하되, 숙성액을 감압농축하는 대신에 1기압 80℃의 온도로 가열하여 농도가 13Brix가 되도록 하였고, 유효성분 추출액 역시 감압농축하는 대신에 1기압 80℃의 온도로 가열하여 23Brix가 되도록 하였다It was carried out in the same manner as in Example 1, but instead of concentrating the aging solution under reduced pressure, it was heated to a temperature of 80°C at 1 atmosphere so that the concentration was 13 Brix, and the extract of the active ingredient was also heated to a temperature of 80°C at 1 atmosphere instead of concentration under reduced pressure. To make 23Brix
(비교예 4)(Comparative Example 4)
실시예 1과 동일하게 실시하되, 숙성액을 감압농축 과정을 생략하였다.The same procedure as in Example 1 was carried out, but the process of concentration under reduced pressure in the aged liquid was omitted.
..
(비교예 5)(Comparative Example 5)
타사 제품(양파즙)을 이용하는 대신에, 실시예 1과 동일하게 실시하되, 양파껍질을 까지 않고(즉, 숙성 기간 생략) 생양파 1kg(5개에서 6개 분량임)을 으깬 후에 상온에서 50% 에탄올 1kg을 투여하여 5시간 기다려 유효 성분 추출액이 되도록 하고, 이러한 유효 성분 추출액을 압력 40cmHg 하의 73℃의 온도에서 감압농축하여 농도가 23 Brix가 되도록 하였다.Instead of using a third-party product (onion juice), it was carried out in the same manner as in Example 1, but crushed 1 kg of raw onion (5 to 6 portions) without peeling onion (i.e., ripening period) and then at room temperature. 1 kg of ethanol was administered to wait 5 hours to be an active ingredient extract, and the active ingredient extract was concentrated under reduced pressure at a temperature of 73° C. under a pressure of 40 cmHg to obtain a concentration of 23 Brix.
이러한 비교예들과 실시예를 상술한 항암세포 테스트의 결과가 도 6 내지 도 9에 도시되었다.The results of the anticancer cell test described above with respect to these comparative examples and examples are shown in FIGS. 6 to 9.
비교 결과 (실시예 1)의 경우가 다른 비교예들과 비교할 때도 각 항암세포에 대한 테스트에서 세포단계 항암 효과를 확인할 수 있었다.When the results of the comparison (Example 1) were compared with other comparative examples, the anti-cancer effect at the cell level was confirmed in the test for each anti-cancer cell.
즉, 양파 껍질을 분리하여 저온 숙성을 장기간 하고, 또한 알콜추출법을 이용함에 있어서도, 양파 껍질에 대한 알콜농도가 껍질이 제거된 양파에 대한 알콜농도보다 더 높게 하고, 특히 감압추출을 이용하여 알콜을 제거한 경우가 항암 테스트에서 더욱 우수한 효과를 보이고 있음을 알 수 있다.In other words, by separating the onion peels for a long period of low temperature aging, and also using an alcohol extraction method, the alcohol concentration for the onion peel is higher than the alcohol concentration for the onion from which the peel has been removed, and in particular, alcohol is used by using reduced pressure extraction. It can be seen that the removed case shows a better effect in the anticancer test.
이는 양파 껍질을 별도로 분리하여 저온 숙성하는 경우, 양파 껍질에 대한 알콜추출법에는 양파에 대한 알콜추출법과는 다른 고농도의 알콜을 이용하는 경우, 또한 알콜추출법을 이용할 때 상온에서 하기 보다는 압력을 낮추고 상대적으로 저온인 상태에서 처리하는 경우가, 양파 껍질의 숙성액에 대한 감압농축 과정을 먼저 한 경우가, 암세포 사멸을 위한 유효물질들을 많이 배출하는 것으로 해석될 수 있다.In this case, when the onion peel is separated and aged at a low temperature, the alcohol extraction method for the onion peel uses a high concentration of alcohol different from the alcohol extraction method for onion, and also uses the alcohol extraction method to lower the pressure and lower the pressure rather than at room temperature. In the case of processing in the phosphorus state, the case where the decompression concentration process for the ripening solution of the onion peel was first performed may be interpreted as releasing a large amount of active substances for the death of cancer cells.
특히, 도 10에는 양파에서 추출되는 유효 성분들 중에서 케르세틴의 농도를 서로 비교한 결과를 나타내고 있다.In particular, FIG. 10 shows the results of comparing the concentrations of quercetin among active ingredients extracted from onions.
앞선 실시예 및 각 비교군, 비교예에 의해 제조된 각각의 추출물에 포함되어 있는 케르세틴 농도의 측정은 HPLC법(High Performance Liquid Chromatography method)을 이용하여 측정하였다.The measurement of the quercetin concentration contained in each of the extracts prepared by the previous examples and each comparative group and comparative example was measured using a HPLC method (High Performance Liquid Chromatography method).
HPLC법을 수행하기 위하여, 각 실시예서 제조된 각각의 추출물에 대해서 전처리를 수행하였다.In order to perform the HPLC method, pretreatment was performed for each extract prepared in each example.
예를 들어 전처리는 실시예 1에서 제조된 유효성분 추출액 약 50mL를 300 mL 용량의 분액여두에 넣고 동량의 에틸 아세테이트(ethyl acetate)를 가한 후, 300rpm에서 5분간 흔들고 방치하여 상분리를 시켰다.For example, pre-treatment was performed by adding about 50 mL of the active ingredient extract prepared in Example 1 into a 300 mL volume separation filter, adding the same amount of ethyl acetate, shaking and standing at 300 rpm for 5 minutes to separate the phases.
상분리 후, 아래 수층을 다른 분액여두로 따라내고 위 에틸 아세테이트층을 증류 플라스크(evaporate flask)로 옮기고, 분액여두로 분리한 수층은 이러한 방법을 총 3회가 되도록 반복하였다.After phase separation, the lower aqueous layer was decanted with another separatory column, the upper ethyl acetate layer was transferred to an evaporate flask, and the aqueous layer separated by separatory distillation was repeated such that the method was three times in total.
이러한 반복과정에 의해 합쳐진 에틸 아세테이트층은 55℃ 수욕상에서 감압 농축하여 용매를 완전히 증발시켜 잔사를 수득하였고, 수득된 잔사에 메탄올 4mL를 넣어 완전히 용해하여 세척한 후, 피펫(Pasteur pipette)을 사용하여 10 mL 크기 플라스크로 옮기고, 플라스크를 다시 메탄올로 세척한 후 세척액을 모두 합치는 과정을 총 3회 반복 후, 메탄올로 표선을 맞추어 10mL로 하여 검액을 실시하였다. 마지막으로 13 mm PVDF syringe filter(Whatman, 0.45㎛)로 필터링(filtering)을 수행하여 HPLC 시료로 사용하였다.The ethyl acetate layer combined by this repeating process was concentrated under reduced pressure in a 55° C. water bath to evaporate the solvent completely to obtain a residue, and 4 ml of methanol was completely dissolved in the obtained residue, washed completely, and then used a pipette (Pasteur pipette). After transferring to a 10 mL size flask and washing the flask again with methanol, the process of combining the washing solutions was repeated three times in total. Finally, filtering was performed with a 13 mm PVDF syringe filter (Whatman, 0.45 µm) and used as an HPLC sample.
케르세틴 농도 측정을 위한 HPLC system(YOUNGLIN INSTRUMENT, 대한민국)은 Solvent Delivery Pump(Model M930D); Absorbance Detector(Model M730D); Column Oven(Model CTS30) 및 Solvent Degassor & Valve Module(Model SDB30 plus)으로 구성되어 있으며, HPLC 시스템에 의해 분리된 케르세틴의 검출은 자외부흡 광광도계를 이용하여 측정파장 370 nm에서 수행하였다. HPLC system for measuring quercetin concentration (YOUNGLIN INSTRUMENT, Korea) includes: Solvent Delivery Pump (Model M930D); Absorbance Detector (Model M730D); It consists of Column Oven (Model CTS30) and Solvent Degassor & Valve Module (Model SDB30 plus), and the detection of quercetin separated by an HPLC system was performed at a measurement wavelength of 370 nm using an ultraviolet absorption photometer.
HPLC를 이용한 분석을 위해, 분석컬럼은 ODSHYPERSIL(Thermo ELECTRON CO., Model 30105-154630)을 사용하였고, 구체적인 사양으로 분석 안지름 약 5mm, 길이 약 15cm인 스테인레스 강관에 5um 의 C18로 충전하였으며, 컬럼의 온도는 상온으로 설정하였고, 이동상은 증류수(Milli-Q water)와 메탄올 혼합액(60:40)에 TFA (trifloroacetic acid)를 0.04% 농도로 첨가한 용액을 사용하였으며, 이동상의 solvent flow rate는 1 mL/min이고, 이동시간은 30분으로 설정하였다. 또한, 상기 HPLC를 수행하기 위한 시료(sample)의 injection volumn은 10ul이었다.For the analysis using HPLC, the analysis column used ODSHYPERSIL (Thermo ELECTRON CO., Model 30105-154630), and as a specific specification, it was filled with 5 μm C18 in a stainless steel pipe having an analysis inside diameter of about 5 mm and a length of about 15 cm, and the column was The temperature was set to room temperature, and the mobile phase used a solution in which 0.04% of TFA (trifloroacetic acid) was added to distilled water (Milli-Q water) and methanol mixture (60:40), and the solvent flow rate of the mobile phase was 1 mL. /min, and the moving time was set to 30 minutes. In addition, the injection volumn of the sample for performing the HPLC was 10 ul.
이러한 방법에 의해 측정된 케르세틴 표준 물질의 HPLC 분석결과는 도 10과 같다.The result of HPLC analysis of the quercetin standard material measured by this method is shown in FIG. 10.
케르세틴 농도 측정을 위한 표준 케르세틴(quercetin standard)는 Quercetin dehydrate(minimum 98% HPLC, SIGMA, USA)를 사용하였다.Quercetin dehydrate (minimum 98% HPLC, SIGMA, USA) was used as a standard quercetin standard for measuring quercetin concentration.
보다 상세하게는, 상기 표준 케르세틴 50, 100, 200, 5000, 10000 및 20000 ppm의 농도로 HPLC 분석을 실시하여, 일차방정식(y = ax + b)으로 표준곡선(standard curve)을 작성하였다.More specifically, by performing HPLC analysis at the concentrations of the
실시예들에서 제조된 추출물의 케르세틴 농도(함량)의 측정 및 계산은 해당 추출물을 시료(sample)로 HPLC 분석을 실시한 후, 분석결과에 의해 측정된 케르세틴 영역(quercetin peak area)을 기 공지된 수식(케르세틴 농도(ppm) = (a ㅧ 케르세틴 영역 + b) ㅧ 10(희석배수))에 대입하여 계산하고 , 여기서 계산식에 곱하는 값은 시료의 전처리 과정에서 있었던 메탄올 희석배수(10배)를 의미한다.The measurement and calculation of the quercetin concentration (content) of the extracts prepared in the Examples is carried out by HPLC analysis of the extract as a sample, and the quercetin peak area measured by the analysis results is known formula. Calculated by substituting for (Quercetin concentration (ppm) = (a ㅧ Quercetin region + b) 여기서 10 (dilution multiple)), where the value multiplied by the formula means the dilution factor of methanol (10 times) during the pretreatment of the sample. .
도 10에 도시된 바와 같이 동일한 양의 양파로부터 추출되는 케르세틴 농도는 본 발명의 실시예 1인 경우임을 알 수 있고, 이러한 케르세틴 추출량 증가에 따라 앞서 설명한 항암 효과가 나타난 것으로 판단된다.As shown in FIG. 10, it can be seen that the quercetin concentration extracted from the same amount of onion is the case of Example 1 of the present invention, and it is determined that the anticancer effect described above was exhibited according to the increase in quercetin extract amount.
본 발명은 상기한 특정 실시예에 한정되는 것이 아니라 본 발명의 요지를 벗어나지 않는 범위 내에서 여러 가지로 변형 및 수정하여 실시할 수 있는 것이다. 이러한 변형 및 수정이 첨부되는 청구범위에 속한다면 본 발명에 포함된다는 것은 자명할 것이다. The present invention is not limited to the specific embodiments described above, but can be implemented by various modifications and modifications without departing from the gist of the present invention. It will be apparent that such variations and modifications are included in the present invention if they fall within the scope of the appended claims.
Claims (7)
(b) 상기 (a) 단계에서 분리된 양파 껍질을 용매를 이용하여 숙성시켜 숙성액을 생성하는 단계와;
(c) 껍질이 제거된 생양파를 작은 크기로 부수는 단계와;
(d) 상기 (b) 단계의 숙성액과 상기 (c) 단계에서 가공된 생양파를 혼합하여 혼합액을 생성하는 단계와;
(e) 상기 (d) 단계의 혼합액에 용매를 투입하여 유효성분 추출액을 생성하는 단계와;
(f) 상기 (e) 단계의 유효성분 추출액에서 용매를 제거하는 단계를 포함하고,
상기 (b) 단계의 용매와 상기 (e) 단계의 용매는 에탄올이고, 상기 (b) 단계에서는 분리된 양파 껍질을 65% ~ 75% 에탄올을 이용하여 숙성시켜 숙성액을 생성하며, 상기 (e) 단계에서는 상기 (d) 단계의 혼합액에 45% ~ 55% 에탄올을 투입하여 유효성분 추출액을 생성하고,
(g) 상기 (b) 단계 이후에, 상기 (b) 단계의 에탄올을 제거하는 단계를 더 포함하고,
상기 (b) 단계의 숙성 기간은 18개월 ~ 24개월이고, 7℃ ~ 12℃ 이하에서 저온 숙성하는 것을 특징으로 하는 양파즙 제조 방법.(A) after washing the onion, separating the peel;
(B) a step of aging the onion peel separated in the step (a) using a solvent to produce a aging solution;
(c) crushing the peeled raw onion into small sizes;
(d) mixing the aged liquid of the step (b) with the raw onion processed in the step (c) to produce a mixed liquid;
(e) generating an active ingredient extract by adding a solvent to the mixed solution of step (d);
(f) removing the solvent from the active ingredient extract of step (e),
The solvent of the step (b) and the solvent of the step (e) are ethanol, and in the step (b), the separated onion peel is aged using 65% to 75% ethanol to generate a aging solution, and the (e) In step ), an active ingredient extract is generated by adding 45% to 55% ethanol to the mixed solution of step (d),
(g) after step (b), further comprising the step of removing ethanol in step (b),
The ripening period of step (b) is 18 months to 24 months, and onion juice production method characterized in that it is aged at a low temperature of 7°C to 12°C.
상기 (g) 단계에서는, 상기 (b) 단계의 숙성액을 80℃ ~ 85℃의 온도에서 에탄올을 제거하고,
상기 (f) 단계에서는, 상기 (e) 단계의 유효성분 추출액을 80℃ ~ 85℃의 온도에서 에탄올을 제거하는 것을 포함하는 것을 특징으로 하는 양파즙 제조 방법.According to claim 1,
In step (g), the aging liquid of step (b) is removed from ethanol at a temperature of 80°C to 85°C,
In the step (f), the method for producing onion juice, characterized in that it comprises removing the ethanol at a temperature of 80 ℃ ~ 85 ℃ the active ingredient extract of the step (e).
상기 (g) 단계에서는, 상기 (b) 단계의 숙성액을 70℃ ~ 75℃의 온도, 압력 40cmHg에서 감압 농축하여 농도가 10 ∼ 15 Brix가 되도록 하는 것을 특징으로 하는 양파즙 제조 방법.
상기 (f) 단계에서는, 상기 (e) 단계의 유효성분 추출액을 70℃ ~ 75℃의 온도, 압력 40cmHg에서 감압농축하여 농도가 20 ∼ 25 Brix가 되도록 하는 것을 특징으로 하는 양파즙 제조 방법.
According to claim 1,
In the step (g), the method of producing onion juice, characterized in that the concentration of the aging liquid of the step (b) is concentrated under reduced pressure at a temperature of 70°C to 75°C and a pressure of 40 cmHg so as to have a concentration of 10 to 15 Brix.
In the step (f), the method for producing onion juice, characterized in that the concentration of the active ingredient extract of step (e) is concentrated under reduced pressure at a temperature of 70° C. to 75° C. and a pressure of 40 cmHg so as to have a concentration of 20 to 25 Brix.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200050238A KR102141609B1 (en) | 2020-04-24 | 2020-04-24 | Manufacturing method for onion juice |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200050238A KR102141609B1 (en) | 2020-04-24 | 2020-04-24 | Manufacturing method for onion juice |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102141609B1 true KR102141609B1 (en) | 2020-08-06 |
Family
ID=72040207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200050238A KR102141609B1 (en) | 2020-04-24 | 2020-04-24 | Manufacturing method for onion juice |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102141609B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230161560A (en) | 2022-05-18 | 2023-11-28 | 정도원농업회사법인 (주) | Manufacturing method of onion juice with improved nutritional content and preference |
KR20240025196A (en) | 2022-08-18 | 2024-02-27 | 이지형 | source to improve blood sugar containing organic vanadium |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002186449A (en) * | 2000-12-21 | 2002-07-02 | Ogawa & Co Ltd | Method for producing essence of plant of genus allium |
KR100794300B1 (en) * | 2006-07-14 | 2008-01-14 | 정재곤 | Manufacturing method of onion juice and drink water using it |
KR20110033348A (en) * | 2009-09-25 | 2011-03-31 | 창원대학교 산학협력단 | Method for preparation of onion process residuum extract having antioxidant and fibrinolysis |
EP2454950B1 (en) * | 2009-07-17 | 2014-09-03 | Takasago International Corporation | Onion extract, and process for production thereof |
KR20160088165A (en) * | 2015-01-15 | 2016-07-25 | 경상대학교산학협력단 | Composition for improvement of learning and memory function comprising onion extract or its fraction as effective component |
KR101791206B1 (en) | 2015-07-28 | 2017-10-31 | 초당대학교 산학협력단 | The onion juice and method of it |
KR20180129579A (en) * | 2017-05-25 | 2018-12-05 | 주정원 | Onion Coat composition Using An Enzyme With Stevia Extract And Method thereof |
-
2020
- 2020-04-24 KR KR1020200050238A patent/KR102141609B1/en active IP Right Grant
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002186449A (en) * | 2000-12-21 | 2002-07-02 | Ogawa & Co Ltd | Method for producing essence of plant of genus allium |
KR100794300B1 (en) * | 2006-07-14 | 2008-01-14 | 정재곤 | Manufacturing method of onion juice and drink water using it |
EP2454950B1 (en) * | 2009-07-17 | 2014-09-03 | Takasago International Corporation | Onion extract, and process for production thereof |
KR20110033348A (en) * | 2009-09-25 | 2011-03-31 | 창원대학교 산학협력단 | Method for preparation of onion process residuum extract having antioxidant and fibrinolysis |
KR20160088165A (en) * | 2015-01-15 | 2016-07-25 | 경상대학교산학협력단 | Composition for improvement of learning and memory function comprising onion extract or its fraction as effective component |
KR101791206B1 (en) | 2015-07-28 | 2017-10-31 | 초당대학교 산학협력단 | The onion juice and method of it |
KR20180129579A (en) * | 2017-05-25 | 2018-12-05 | 주정원 | Onion Coat composition Using An Enzyme With Stevia Extract And Method thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230161560A (en) | 2022-05-18 | 2023-11-28 | 정도원농업회사법인 (주) | Manufacturing method of onion juice with improved nutritional content and preference |
KR20240025196A (en) | 2022-08-18 | 2024-02-27 | 이지형 | source to improve blood sugar containing organic vanadium |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Medina et al. | Characterization of bioactive compounds in commercial olive leaf extracts, and olive leaves and their infusions | |
Romani et al. | An industrial and sustainable platform for the production of bioactive micronized powders and extracts enriched in polyphenols from Olea europaea L. and Vitis vinifera L. wastes | |
Khiraoui et al. | Nutritional and biochemical properties of natural sweeteners of six cultivars of Stevia rebaudiana Bertoni leaves grown in Morocco | |
Madureira et al. | Applications of bioactive compounds extracted from olive industry wastes: A review | |
Farag et al. | Valorization and extraction optimization of Prunus seeds for food and functional food applications: A review with further perspectives | |
Singh et al. | Extraction of antioxidant phytoconstituents from onion waste | |
KR102141609B1 (en) | Manufacturing method for onion juice | |
KR101316091B1 (en) | Health assistance food using dendropanax morbifera and manufacturing method thereof | |
KR100626398B1 (en) | Mixtures of antioxidand supplement for current or former smokers and manufacturing method therof | |
Zein et al. | The antioxidant and anticancer activities of Swiss chard and red beetroot leaves | |
Anil et al. | Food function and health benefits of functional foods | |
KR20170118427A (en) | health food composition for improving andropause syndrome | |
KR102387371B1 (en) | Fermented Stauntonia hexaphylla with improved antioxidant activity and uses thereof | |
Shi et al. | Antioxidants extraction by supercritical CO2 | |
KR101263356B1 (en) | Food composition for the oral purpose with anti-inflammatory activity | |
KR102080410B1 (en) | Composition for Preventing, Treating or Improving of Andropause Syndrome Comprising Elderberry Extracts | |
Jamini et al. | Roselle (Hibiscus sabdariffa L.): Nutraceutical and Pharmaceutical Significance | |
Winifred et al. | Biochemical studies of the ameliorating effects of bitter leaf and scent leaf extracts on diabetes mellitus in humans | |
Lal et al. | Traditional, medicinal and nutraceutical values of minor fruit: Longan | |
Atanassova et al. | Studies on nutritional facts of spring herbs collected from Bulgarian market | |
CN108497246A (en) | A kind of plant weight losing function beverage and preparation method thereof | |
CN116801873A (en) | Compositions comprising flavanol monomers and E-grape | |
STAN et al. | JUJUBE PROCESSING: METHODS, PRODUCTS AND NUTRACEUTICAL VALUE. | |
KR101786463B1 (en) | Composition of the metabolic syndrome as an active ingredient the essential oil components of those Litsea japonica and a manufacturing method thereof | |
Azhar et al. | The Effect of maltodextrin concentration and inlet air temperature on spray dried Centella asiatica L. powder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |